How were 3SBio's earnings last quarter?

3SBio Inc (NASDAQ:SSRX) released its quarterly earnings data on Monday, March, 18th. The biotechnology company reported $0.12 earnings per share for the quarter, missing analysts' consensus estimates of $0.14 by $0.02. The biotechnology company had revenue of $26.30 million for the quarter, compared to the consensus estimate of $25.63 million.

What other stocks do shareholders of 3SBio own?

Based on aggregate information from My MarketBeat watchlists, some companies that other 3SBio investors own include Regeneron Pharmaceuticals (REGN) , Allena Pharmaceuticals (ALNA) , Ampliphi Biosciences (APHB) , Arbutus Biopharma (ABUS) , Aurora Cannabis (ACBFF) , AcelRx Pharmaceuticals (ACRX) , Aldeyra Therapeutics (ALDX) , Apellis Pharmaceuticals (APLS) and

NASDAQ:SSRX

3SBio (SSRX) Stock Price, News & Analysis

→ Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad)

Free SSRX Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: 149,084 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get 3SBio alerts:

Ad Manward Press

Can't believe it's happening again

One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.

We explain how this event works in full right here.

About 3SBio Stock (NASDAQ:SSRX)

3SBio Inc. is a biotechnology company in the People's Republic of China with research and development, manufacturing, and marketing capabilities focusing on bio-pharmaceutical products. The Company recombinant, or genetically engineered, protein-based products and product candidates are designed to address markets with unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. Its principal products are EPIAO and TPIAO. In addition, it has two legacy products, Intefen and Inleusin; and an in-licensed product, Iron Sucrose Supplement. The Company focuses on its research and development efforts on both novel and validated protein-based therapeutics for the treatment of diseases in the areas of nephrology, oncology, supportive cancer care, inflammation and infectious diseases, and other selected areas. In May 2013, the Company merged with Decade Sunshine Limited and Decade Sunshine Merger Sub.

Ad Manward Press

Can't believe it's happening again

We explain how this event works in full right here.

SSRX Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive SSRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 3SBio and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/18/2013
Today: 4/16/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: N/A
Industry: N/A
Sub-Industry: N/A
Current Symbol: NASDAQ:SSRX
CUSIP: N/A
CIK: 1383790
Web: www.3sbio.com
Phone: +86-24-25811820
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

Jing Lou (Age 54)
Executive Chairman of the Board, Chief Executive Officer
Bo Tan (Age 44)
Chief Financial Officer, Executive Vice President, Executive Director
Fei You (Age 38)
Director - Finance
Weihonghas Xiao (Age 48)
Chief Operating Officer
Dongmei Su (Age 46)
Senior Vice President, Executive Director
Zhenping Zhu MD. Ph.D. (Age 52)
Chief Scientific Officer, President - Research & Development
Bin Huang (Age 56)
Vice President, Executive Director
Xin Ma (Age 51)
Vice President - Human Resources
Yongfu Chen (Age 60)
Vice President
Kevin Liu (Age 47)
Vice President

SSRX Stock Analysis - Frequently Asked Questions

How were 3SBio's earnings last quarter?: 3SBio Inc (NASDAQ:SSRX) released its quarterly earnings data on Monday, March, 18th. The biotechnology company reported $0.12 earnings per share for the quarter, missing analysts' consensus estimates of $0.14 by $0.02. The biotechnology company had revenue of $26.30 million for the quarter, compared to the consensus estimate of $25.63 million.
What other stocks do shareholders of 3SBio own?: Based on aggregate information from My MarketBeat watchlists, some companies that other 3SBio investors own include Regeneron Pharmaceuticals (REGN), Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Apellis Pharmaceuticals (APLS) and

This page (NASDAQ:SSRX) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

3SBio (SSRX) Stock Price, News & Analysis

About 3SBio Stock (NASDAQ:SSRX)

SSRX Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

SSRX Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info